INCY - Incyte to acquire immune-focused drug developer Escient
2024-04-23 07:31:43 ET
More on Incyte
- Incyte: A Potential GARP Superstar
- Incyte Corporation (INCY) Q4 2023 Earnings Call Transcript
- Incyte Corporation 2023 Q4 - Results - Earnings Call Presentation
- Incyte and CMS collaborate for povorcitinib in Mainland China, Hong Kong, Macau, Taiwan and SEA
- FDA accepts Incyte application for graft-versus-host disease drug